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Abstract
Running a marathon causes strenuous joint loading and increased energy expenditure. Adipokines regulate energy
metabolism, but recent studies have indicated that they also exert a role in cartilage degradation in arthritis. Our aim was to
investigate the effects of running a marathon on the levels of adipokines and indices of cartilage metabolism. Blood
samples were obtained from 46 male marathoners before and after a marathon run. We measured levels of matrix
metalloproteinase-3 (MMP-3), cartilage oligomeric protein (COMP) and chitinase 3-like protein 1 (YKL-40) as biomarkers of
cartilage turnover and/or damage and plasma concentrations of adipokines adiponectin, leptin and resistin. Mean marathon
time was 3:30:4660:02:46 (h:min:sec). The exertion more than doubled MMP-3 levels and this change correlated negatively
with the marathon time (r = –0.448, p = 0.002). YKL-40 levels increased by 56% and the effect on COMP release was variable.
Running a marathon increased the levels of resistin and adiponectin, while leptin levels remained unchanged. The
marathon-induced changes in resistin levels were positively associated with the changes in MMP-3 (r = 0.382, p = 0.009) and
YKL-40 (r = 0.588, p,0.001) and the pre-marathon resistin levels correlated positively with the marathon induced change in
YKL-40 (r = 0.386, p = 0.008). The present results show the impact of running a marathon, and possible load frequency, on
cartilage metabolism: the faster the marathon was run, the greater was the increase in MMP-3 levels. Further, the results
introduce pro-inflammatory adipocytokine resistin as a novel factor, which enhances during marathon race and associates
with markers of cartilage degradation.
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Introduction
Moderate recreational activity is an effective mean to improve
health showing many long-term benefits: improved lung and heart
function, muscle strength and metabolic health among other
things. However, after intensive exercise, such as marathon,
markers of muscle damage, oxidative stress and inflammation are
often found [1,2]. Running has beneficial effects on knee articular
cartilage, but elite athletes who perform their activities with high
impacts and exert high stresses on their joints appear to have
increased risk to develop osteoarthritis and the concomitant
presence of joint injury further increases this risk [3]. The effects of
joint loading caused by exercise were investigated in the recent
MRI study by Mosher et al. [4]. Those authors found that there
was measurable compression of cartilage after 30 min of running.
There are also reports on the effects of joint loading and exercise
on the release of biomarkers of cartilage turnover and/or damage
focusing mainly on COMP but little is known about more recent
biomarkers MMP-3 and YKL-40 which are known to associate
with cartilage degradation in inflammatory arthritis and/or
osteoarthritis [5–13].
Adipokines (also known as adipocytokines) adiponectin, leptin
and resistin, are hormones that were initially found to be secreted
by adipocytes and to regulate energy metabolism linking
nutritional status to neuroendocrine function [14]. Interestingly,
more recent findings on the ubiquitous expression of their
receptors and on their cellular effects have revealed that
adipokines are produced by joint tissues and can act as regulatory
factors in inflammatory arthritis as well as in osteoarthritis. We
and others have recently shown that those adipokines are
especially associated with cartilage destruction in osteoarthritic
joints [15–18]. Running a marathon or some other long-duration
exercises have been reported either to decrease or not to have any
effect on leptin levels [19–22], but as far as we are aware the effects
of marathon running on adiponectin and resistin levels have not
previously been investigated. Further, the association of adipokines
with cartilage degradation in relation to strenuous exercise like
marathon run has not been previously studied although such a
relationship could be hypothesized based on osteoarthritis studies.
The aim of the present study was to investigate the effects of
marathon running on the levels of adipokines adiponectin, leptin
and resistin, as well as on markers associated with cartilage
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degradation in inflammatory arthritis and osteoarthritis; i.e.
COMP, MMP-3 and YKL-40, in an attempt to further
understand the effects of running associated strenuous loading
on articular cartilage. The present results highlight the impact of
long distance running on cartilage metabolism and imply that load
frequency increases cartilage turnover/damage: the faster the
marathon was run, the greater the increase in the MMP-3 level.
Also YKL-40 levels were increased, while the effect on COMP was
variable. Further, the results introduce the proinflammatory
adipocytokine resistin as a novel factor increased during strenuous
exercise and associated with markers of cartilage degradation.
Methods
Subjects
The subjects were recruited among those planning to participate
in the Helsinki City Marathon (42.195 km) through an advertise-
ment in a national runners’ magazine and by sending a
recruitment letter to previous Helsinki City Marathon participants.
The subjects were eligible for the study if they were healthy and
their personal-best marathon time was less than 3 h 30 min.
Because of gender-related differences in adipokine concentrations,
only males were included in the study. The subjects provided their
written informed consent before entering the study. During the
marathon, the subjects were permitted to ingest fluids and food
freely. The study was approved by the Ethics Committee of the
Hospital District of Helsinki and Uusimaa, Finland and was
conducted according to the principles expressed in the Declaration
of Helsinki.
Blood samples
Venous blood samples were taken from the antecubital vein into
EDTA tubes on the day before the marathon and after the race.
Blood samples were taken in the Helsinki Olympic Stadium before
and after the marathon run, sent immediately to the laboratory,
centrifuged and the resulting plasma stored as aliquots at 280uC
until analyzed.
Laboratory analyses
Concentrations of adiponectin, leptin, resistin, MMP-3, COMP
and YKL-40 in plasma samples were determined by enzyme-
linked immunosorbent assay (ELISA) with commercial reagents
(adiponectin, leptin, resistin, MMP-3 and YKL-40: R&D Systems,
Europe Ltd, Abindgon, UK; COMP: Biovendor, Modrice, Czech
Republic). Hematological parameters were determined using an
electronic counter (Coulter MAXM hematology analyzer, Beck-
man Coulter, Fullerton, CA). Changes in plasma volume due to
the marathon run were estimated using hematological parameters
as described by Dill and Costill [23] and results presented were
corrected for changes in plasma volume.
Statistical analysis
Data were analyzed using SPSS 19.0 software for Windows
(SPSS Inc., Chicago, IL, USA). The results are presented as
median and mean, interquartile range, minimum and maximum
score, and outliers, unless otherwise indicated. The normality of
the distributions of the analytes were tested with Kolmogorov-
Smirnov’s test. Changes in plasma levels of adipokines and
biomarkers before and after the marathon were analysed with two-
tailed paired t-test or Wilcoxons test, where appropriate. Pearson
and Spearman correlation analysis were used when appropriate
according to the distribution of the data. P-values less than 0.05
were considered as statistically significant.
Results
Forty six (46) men (Table 1) completed the marathon and were
included in the study. marathon time was 3:30:4660:02:46 h:min:
sec (mean6SEM). The mean change in plasma volume due to the
marathon run was21.760.9% and thus the results presented below
are corrected for changes in plasma volume.
The adiponectin level measured before the marathon race was
31426145 ng/ml; leptin concentration 1.760.2 ng/ml, and
resistin concentration 13.760.5 ng/ml. None of the adipokines
showed correlation to BMI at baseline. After the marathon race,
resistin levels had been increased by 107% (p,0.001) and those of
adiponectin by 13% (p,0.001), but there was no change in the
leptin levels (Fig. 1).
The pre-marathon level of MMP-3 was 26.661.1 ng/ml and
running the marathon more than doubled the MMP-3 concen-
tration (142% increase, p,0.001, Fig. 2a). The YKL-40 level was
63.869.5 ng/ml before the marathon race and after the run
YKL-40 level had increased by 56% (p,0.001, Fig. 2b). Before
the marathon, the COMP concentration was 996.2644.4 ng/ml
and the mean level of COMP showed no change after the race
(Fig. 2c).
MMP-3 levels were increased in all of the marathoners and
furthermore, the marathon induced change in the MMP-3
concentration was negatively correlated with the marathon time
(r = 20.448, p = 0.002, Fig. 3a), i.e. the faster the marathon was
run, the greater the increase in the MMP-3 level. Interestingly, the
increase detected in resistin levels was associated positively with
the increase in MMP-3 levels (r = 0.382, p = 0.009, Fig. 3b).
The marathon increased YKL-40 levels in all of the runners.
Pre-marathon resistin levels predicted the change in YKL-40 levels
(r = 0.386, p= 0.008, Fig. 4a) and, interestingly, the marathon
induced increase in resistin levels correlated positively with the
elevation of the YKL-40 concentrations (r = 0.588, p,0.001,
Fig. 4b).
Although the average COMP levels did not change (Fig. 2),
there was variation between the runners; maximum individual
increase in COMP was 493.6 ng/ml, while it was decreased in
some subjects. Low adiponectin and high leptin pre-marathon
levels predicted a greater increase in COMP concentration (r =
20.365, p = 0.013 for adiponectin and r = 0.528, p,0.001 for
leptin, Table 2).
Discussion
Although moderate exercise is beneficial for the joint and
articular cartilage [3], marathon running is suspected to exert
unusually strenuous joint loading. We detected clear increases in
known biomarkers of cartilage turnover and/or damage: MMP-3
levels increased by 142% and YKL-40 levels by 56%. In addition,
Table 1. Demographic data on the 46 male marathoners
participating in the study.
Characteristic Mean SD
Age, years 40.3 9.9
Body-mass index, kg/m2 22.3 1.2
Marathon time h:min:sec 3:30:46 0:18:47
Hemoglobin, g/l 147.6 7.8
Hematocrit, % 44.0 2.5
doi:10.1371/journal.pone.0110481.t001
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the marathon induced change in the MMP-3 level was negatively
correlated with the marathon time (r = 20.448, p = 0.002), i.e.
the faster the marathon was run, the greater the increase in the
MMP-3 level.
In arthritis research, increased levels of MMP-3, YKL-40 and
COMP in the circulation are recognized as biomarkers of cartilage
turnover and/or destruction [24]. MMP-3 is a protease strome-
lysin produced by synovial tissue and cartilage and involved in
cartilage matrix degradation and inflammation inside joints. YKL-
40 is a glycoprotein belonging to the chitinase family secreted by
cartilage, synovium, macrophages and cells of epithelial origin and
involved in cartilage catabolism [24]. COMP is a cartilage matrix
component, which is known to be released during cartilage
degeneration [10,24]. To our knowledge, there are no previous
reports on the effect of running a marathon on MMP-3 or YKL-
40 levels. In the present study, the strenuous exercise of a
marathon race more than doubled the circulating levels of MMP-3
and this correlated negatively with the time to complete the race;
the YKL-40 level was elevated by 56%, while the average COMP
concentration showed no change after the run. However, there
was variation between the runners; COMP levels remained
unaltered or slightly decreased in some of the runners, while they
increased in the others, the maximal individual increase being
493.6 ng/ml. Accordingly, there are reports on increased and
decreased levels of COMP following joint loading [5–7,9,10]. In
general, our results highlight the marathon related increase in
MMP-3 and YKL-40 which are recognized biomarkers of
cartilage degradation associated with arthritis.
Adipokines leptin, adiponectin and resistin have recently been
associated with inflammation and cartilage destruction in arthritis
[25]. On the other hand, the length and energy expenditure in a
single workout have been demonstrated to exert acute effects on
adipokine levels [26]. Those series of knowledge led us to measure
the changes in adipokine levels during a marathon race. To our
knowledge, this is the first study to investigate the effects of
marathon running on adiponectin and resistin levels. The race
appeared to have significant effects on those adipokines: during the
marathon, the resistin levels more than doubled and an increase
was seen also in the adiponectin levels. Interestingly, the marathon
induced elevation in the resistin concentrations was associated with
the increases in MMP-3 and YKL-40 levels. Further, a high pre-
marathon resistin level predicted a larger increase in YKL-40
during the run.
Resistin was initially named after its ability to evoke insulin
resistance in rodents, but in humans the relation between resistin
and insulin resistance or BMI is less clear [14]. A recent study
revealed that the effects of this mainly macrophage derived
adipocytokine are mediated after its binding to the Toll-like
receptor 4 (TLR4) [27], which is the receptor known also to
mediate many of the effects of bacterial products in the innate
immune response. This finding indicates resistin as a proinflam-
matory cytokine. Previous studies have shown that resistin indeed
has proinflammatory and cartilage destructing properties in joints:
resistin was reported to induce synovial inflammation and cartilage
destruction when injected into the knee joints of healthy mice [28],
to enhance MMP-1, MMP-13 and ADAMTS expression in
human primary chondrocytes [29], to upregulate PGE2, IL-6 and
Figure 1. Adipokine levels before and after the marathon race.
Horizontal solid and dashed bars within the boxes represent median
and mean, respectively, boxes represent interquartile range and lines
outside boxes represent minimum and maximum. Outliers are
indicated. Paired t-test or Wilcoxons test was used where appropriate.
*** = p,0.001, n = 46.
doi:10.1371/journal.pone.0110481.g001
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IL-8 production in mouse cartilage [30] and to decrease
production of proteoglycan in mouse and in human cartilage
[30]. To our knowledge, there are no previous studies reporting
immediate effects of long-term exercise on resistin levels following
long-term exercise, but the study of Perseghin et al. [31] reported
elevated resistin concentrations in middle-distance and marathon
runners, but not in the sprinters when compared to lean, young
sedentary individuals. We report here that resistin levels doubled
during running a marathon and that was associated with cartilage
load/injury. Resistin is produced primarily by macrophages and
within joints, resistin is also expressed in resident macrophage-like
cells in synovium as well as in osteoblasts and osteoclasts [25,32].
These cellular sources might contribute to the marathon induced
increases locally within joints, which may then leak from the joint
into the circulation. In fact, resistin levels in synovial fluid and in
serum have been shown to increase in patients following knee
injury [30] suggesting that marathon related mechanical joint load
and microtrauma could contribute to the increased circulating
resistin levels found in the present study. However, increased
systemic resistin production cannot be excluded.
Adiponectin levels are low in obese patients, and patients with
impaired glucose tolerance it has been reported to improve insulin
sensitivity and exert antiatherogenic properties [14,33,34]. In
addition, adiponectin has recently been reported to regulate
inflammatory responses in relation to arthritis as well as cartilage
metabolism. In OA, adiponectin has been shown to mediate
cartilage destruction by enhancing the production of proinflam-
matory and cartilage destructing mediators NO, IL-6, MMP-1,
MMP-3 and MMP-13 in primary chondrocytes and in cartilage.
Further, adiponectin has also been found to associate with signs of
cartilage destruction in vivo, i.e. with biomarkers COMP and
MMP-3 and with radiographic severity of OA [15,25]. In humans,
adiponectin is primarily produced by adipocytes, but it is also
expressed in skeletal muscle cells, cardiac myocytes and endothe-
lial cells [14] and released from articular cartilage [15]. The
present study reports a slight increase in adiponectin levels
immediately after a marathon race and based on the present data
it is not possible to determine the origin of the increased adipokine
levels: significant metabolic changes take place both in the adipose
tissue and in the muscle as well as in the cartilage. Interestingly,
exercise has been shown to rapidly activate PPARc in skeletal
muscle, but recently also in monocytes (within 1.5–3 h of exercise)
[35]. Further, Banga et al. showed that PPARc activator
pioglitatzone enhanced the secretion of adiponectin at 4 h
timepoint, having no effect on adiponectin mRNA levels [36].
Result suggests that PPARc activation has rapid posttranslational
effects on e.g. adiponectin assembly and secretion. Exercise-
induced PPARc activation could thus contribute to the reported
adiponectin increase. Since exercise is known to increase insulin
sensitivity [37], it would be tempting to speculate that the elevated
adiponectin level is involved in mediating this effect. Previous data
on the effects of relatively long-term exercise on adiponectin levels
is yet conflicting: apparently adiponectin levels did not exhibit
changes following a 60-minute stationary cycle ergometry session
in a healthy, moderately active group of 8 males and 8 females
[38] or following a 120 min cycling session at 50% VO2max
Figure 2. MMP-3, YKL-40 and COMP as a measure of cartilage
metabolism before and after the marathon. Horizontal solid and
dashed bars within boxes represent median and mean, respectively,
boxes represent interquartile range and lines outside boxes represent
minimum and maximum. Outliers are indicated. Paired t-test or
Wilcoxons test was used where appropriate. *** = p,0.001, n = 46.
doi:10.1371/journal.pone.0110481.g002
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(maximal oxygen uptake) in group of 10 active males [39].
However, intensity and duration of the marathon run may explain
the detected increase in adiponectin levels in the present study.
Leptin is a regulator of energy balance and leptin deficiency in
experimental animals leads to hyperphagia and morbid obesity.
However, increased blood levels of leptin in obese subjects fail to
induce the expected responses, i.e. increased energy expenditure,
and reduced food intake and lowering of body weight indicative of
the appearance of leptin resistance [14]. Since leptin levels fall
rapidly in response to fasting, the nutritional conditions present
during intense exercise may account for the declines in leptin levels
reported after long-term exercise [20–22]. Indeed, Koistinen et al.
[19] showed that leptin levels remain unchanged if the marathon is
run without fasting, but leptin levels do decrease after running a
marathon under fasting conditions. Our study supports this finding
as leptin levels remained unchanged immediately following this
marathon where we imposed no restrictions on the calorie-intake
during the race. According to recent findings, leptin appears also
as an attractive candidate to link obesity, inflammatory mecha-
nisms and osteoarthritis as it has been shown to enhance the
production of proinflammatory cytokines and destructive media-
tors of OA, like NO, IL-6, prostaglandin E2 (PGE2) and MMPs by
articular chondrocytes [25].
Since adipokines are regulatory factors in inflammation and in
cartilage destruction [25] we investigated the possible associations
between concentrations of resistin, adiponectin and leptin and the
Figure 3. Associations of change in MMP-3 level with marathon
time and change in resistin concentration. Marathon induced
change in MMP-3 level was negatively correlated with marathon time
(a), i.e. the faster the marathon was run the more MMP-3 level increased
due to the marathon. Change in MMP-3 level correlated positively with
change in resistin concentration (b). Pearson or Spearman correlation
analyses were used where appropriate, n = 46.
doi:10.1371/journal.pone.0110481.g003
Figure 4. Associations of change in YKL-40 with pre-marathon
level of resistin and change in resistin. Marathon induced change
in YKL-40 was positively correlated with pre-marathon level of resistin,
i.e. high baseline resistin predicted large increase in YKL-40 levels after
the marathon (a). Change in YKL-40 level was also positively correlated
with change in resistin concentration (b). Pearson or Spearman
correlation analyses were used where appropriate, n = 46.
doi:10.1371/journal.pone.0110481.g004
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biomarkers MMP-3, YKL-40 and COMP following marathon
run. The marathon induced changes in the resistin level were
associated with increases in those of MMP-3 and YKL-40. Since it
is known that the TLR4 is a receptor for resistin and that other
activators of TLR4, like lipopolysaccharide (LPS), enhance
production of NO, MMPs and other mediators of cartilage
degradation [40,41], one could speculate that resistin might play a
role in the marathon induced inflammatory response and
contribute to the subsequent catabolic effects on cartilage. We
also found that pre-marathon adipokine levels were associated
with the changes detected in biomarkers reflecting cartilage
turnover and/or damage – a high pre-marathon resistin level
was associated with a larger increase in the YKL-40 level, while
low adiponectin and high leptin levels were related to a greater
increase in the COMP concentration. These findings likely depict
the interacting metabolic and inflammatory properties of the
adipokines [14].
Conclusions
The present results highlight the widespread impact of running
a marathon on cartilage metabolism and imply that loading
frequency increases cartilage turnover/damage: the faster the
marathon was run, the greater the increase in the MMP-3 level. As
an original finding, we report the effects of running a marathon on
two adipokines, adiponectin and resistin which are both associated
with cartilage destruction in inflammatory arthritis and OA:
resistin levels were more than doubled after the run and an
increase was seen also in the adiponectin levels. Interestingly, the
marathon-induced elevation in the resistin concentration was
associated with increases in biomarkers of cartilage degradation
(MMP-3 and YKL-40) and further, a high pre-marathon resistin
concentration predicted a larger increase in the YKL-40 level.
Additional research is needed to clarify whether there is some
causality between resistin and cartilage degradation and whether
adipokines contribute to the marathon related increased risk of
osteoarthritis [3].
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